Mammalian Derived Proteins Market Overview (2022 to 2032)

Expanding at a CAGR of 9.0%, the global mammalian derived proteins market is projected to increase from a valuation of USD 588.9 Million in 2021 to USD 1.5 Bn by 2032.

The increasing prevalence of cancer and fertility conditions among the population, and increasing adoption of hormonal therapies will attribute to the increase in the growth of the mammalian derived proteins market.

The proteins that are isolated from the mammalian system are known as mammalian derived proteins. These proteins are of gold standard in therapeutic applications. Due to the highest possibility of proper binding activity, the mammalian derived proteins are highly used for the production of monoclonal antibodies (MAB), clotting factors, and hormones.

The capability of mammalian cell cultures to synthesize large and complex protein molecules and high tolerance to environmental changes is high. Thus, Mouse myeloma and Chinese hamster ovary cell systems are conventionally used for producing mammalian derived proteins.

Attributes Details
Mammalian Derived Proteins Market Value in 2021 USD 588.9 Million
Mammalian Derived Proteins Market Value in 2032 USD 1.5 Billion
Mammalian Derived Proteins Market CAGR (2022 to 2032) 9.0%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What Are The Major Drivers Boosting The Growth Rate For The Mammalian Derived Proteins Market?

The major factor driving the mammalian derived proteins market is rising prevalence of chronic diseases like cancer and cardiac disorders. This factor act as the biggest driver for the market. Additionally, the increase in the fertility problems has raised the adoption rate of hormonal therapies across the globe.

As most of the fertility hormones are developed through mammalian cell cultures, the global mammalian derived protein market is expected to propel in the near future.

Moreover, utilizing human cell lines for the production of mammalian derived proteins is popular in the industry. Technological advancements in genome engineering has developed different approaches of expression and isolation of proteins for research purpose. This will drive the mammalian derived proteins market in the projected period.

Which Region Shows Strong Growth Potential In The Mammalian Derived Proteins Market?

Owing to the technological development and premier research institutes in the U.S. and Canada, the North American region will lead the mammalian derived proteins market. Also, the growth of the mammalian derived proteins market will be triggered by the rising prevalence of chronic diseases along with the rising infertility issues among people in this region.

Following North America, Europe will lead the market to grow due to the increasing incidence of chronic illness and rising geriatric population. Additionally, strong investment in healthcare structure will boost the market for mammalian derived proteins in Europe. In East Asia, China is estimated to drive market growth with the rising prevalence of cardiovascular diseases.

Due to the less awareness among the population in the regions like Latin America, the Middle East, and Africa, the growth rate for the mammalian derived proteins market is low.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Who Are The Key Manufacturers Of The Mammalian Derived Proteins Market?

Some of the key manufacturers of mammalian derived proteins market are F. Hoffmann-La Roche Ltd, Merck KGaA, Eli Lilly and Company, Lonza., CUSABIO TECHNOLOGY LLC., Prospec-Tany Technogene Ltd., Randox Laboratories Ltd, Geno Technology Inc., Kaneka Eurogentec S.A., Batavia Biosciences., Abnova Corporation, Cayman Chemical, SOSV LLC – IndieBio, and Bioclone Inc.

Scope Of Report

Report Attributes Details
Growth Rate CAGR of 9.0% 2022 to 2032
Base Year for Estimation 2021
Historical Data 2012 to 2021
Forecast Period 2022 to 2032
Qualitative Units Revenue in USD Million and CAGR from 2022 to 2032
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segment Covered

Product, Therapy Area, Application, End User, Region

Region Covered

North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa

Key Countries Profiled

USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC, South Africa, Israel

Key Players

F. Hoffmann-La Roche Ltd; Merck KGaA; Eli Lilly and Company; Lonza.; CUSABIO TECHNOLOGY LLC.; Prospec-Tany Technogene Ltd.; Randox Laboratories Ltd; Geno Technology Inc.; Kaneka Eurogentec S.A.; Batavia Biosciences.; Abnova Corporation; Cayman Chemical; SOSV LLC - IndieBio; Bioclone Inc

Customization Available Upon Request

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Segments Covered In The Mammalian Derived Proteins Industry Survey

By Product:

  • Monoclonal antibodies
  • Clotting factors
  • Hormones
  • Cytokines
  • Others

By Therapy Area:

  • Cancer Therapies
  • Myocardial Infarction
  • Congestive Heart Failure
  • Crohn’s Disease
  • Fertility Treatments
  • Haemophilia
  • Others

By Application:

  • Aptamer development
  • Western blotting
  • ELISA
  • Protein Interaction
  • Protein Structure
  • Cell culture experiments
  • Antibody profiling
  • Improved altered functions
  • Others

By End User:

  • Biotechnology companies
  • Research institutes
  • Contract Research organizations
  • Hospitals

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Frequently Asked Questions

What is the Growth Outlook for the Global Mammalian Derived Proteins Market?

The global mammalian derived proteins market is anticipated to register a CAGR of 9.0% during the forecast period.

What is the Projected Value of the Global Mammalian Derived Proteins Market in 2032?

The mammalian derived proteins market is projected to be about US$ 1.5 Bn by the end of year 2032.

Table of Content
	1. Executive Summary
	2. Industry Introduction, including Taxonomy and Market Definition
	3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
	4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
	5. Pricing Analysis
	6. Global Market Analysis and Forecast
		6.1. Product
		6.2. Therapy Area
		6.3. Application
		6.4. End User
	7. Global Market Analysis and Forecast, By Product
		7.1. Monoclonal antibodies
		7.2. Clotting factors
		7.3. Hormones
		7.4. Cytokines
		7.5. Others
	8. Global Market Analysis and Forecast, By Therapy Area
		8.1. Cancer Therapies
		8.2. Myocardial Infarction
		8.3. Congestive Heart Failure
		8.4. Crohn’s Disease
		8.5. Fertility Treatments
		8.6. Haemophilia
		8.7. Others
	9. Global Market Analysis and Forecast, By Application
		9.1. Aptamer development
		9.2. Western blotting
		9.3. ELISA
		9.4. Protein Interaction
		9.5. Protein Structure
		9.6. Cell culture experiments
		9.7. Antibody profiling
		9.8. Improved altered functions
		9.9. Others
	10. Global Market Analysis and Forecast, By End User
		10.1. Biotechnology companies
		10.2. Research institutes
		10.3. Contract Research organizations
		10.4. Hospitals
	11. Global Market Analysis and Forecast, By Region
		11.1. North America
		11.2. Latin America
		11.3. Europe
		11.4. East Asia
		11.5. South Asia
		11.6. Oceania
		11.7. Middle East & Africa
	12. North America Sales Analysis and Forecast, by Key Segments and Countries
	13. Latin America Sales Analysis and Forecast, by Key Segments and Countries
	14. Europe Sales Analysis and Forecast, by Key Segments and Countries
	15. East Asia Sales Analysis and Forecast, by Key Segments and Countries
	16. South Asia Sales Analysis and Forecast, by Key Segments and Countries
	17. Oceania Sales Analysis and Forecast, by Key Segments and Countries
	18. Middle East & Africa Sales Analysis and Forecast, by Key Segments and Countries
	19. Sales Forecast by Product, Therapy Area, Application, and End User for 30 Countries
	20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
	21. Company Profile
		21.1. Merck KGaA
		21.2. Eli Lilly and Company
		21.3. Lonza
		21.4. CUSABIO TECHNOLOGY LLC.
		21.5. Prospec-Tany Technogene Ltd.
		21.6. Randox Laboratories Ltd
		21.7. Geno Technology Inc.
		21.8. Kaneka Eurogentec S.A.
		21.9. Batavia Biosciences
		21.10. Abnova Corporation
		21.11. Cayman Chemical
		21.12. SOSV LLC - IndieBio
		21.13. Bioclone Inc
		21.14. Rockwell
Recommendations

Healthcare

Difficult to Express Protein Market

July 2024

REP-GB-10062

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Mammalian Derived Proteins Market

Schedule a Call